ClinicalTrials.govpublic full text
Prophylactic Application of Donor-derived TCM After Allogeneic HSCT
leukemia, myeloid, acute, myelodysplastic syndromes, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1044512
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.